Tailoring cyclosporine according to kinetic profiles: does it allow a low-dose therapeutic schedule?

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Transplantation Proceedings

• Publication date

  1987-02-01

• Fields of study

  Medicine

• Identifiers
  PMID 3274416
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reversibility of cyclosporin nephrotoxicity after three months' treatment.

  1985cited by this paper
• INDIVIDUALIZATION OF CYCLOSPORINE THERAPY USING PHARMACOKINETIC AND PHARMACODYNAMIC PARAMETERS

  1985cited by this paper

• Colectomy rate in steroid-refractory colitis initially responsive to cyclosporin: a long-term retrospective cohort study

  2007cites this paper
• Neoral--a new microemulsion formula of cyclosporine A: interpatient pharmacokinetic variability in renal transplant recipients.

  1995cites this paper
• Single-dose response kinetics of oral cyclosporine A: a critical reexamination.

  1992cites this paper
• Pharmacokinetic strategies for cyclosporin therapy in organ transplantation.

  1992cites this paper
• Inter- and intra-subject variation of the suppression of mitogen-induced proliferation of human lymphocytes by cyclosporin-A: reduction of response with delayed addition may be relevant to timing of therapy.

  1991cites this paper
• Monitoring of cyclosporine by serial posttransplant pharmacokinetic studies in renal transplant patients.

  1990cites this paper
• The relationship between cyclosporine pharmacokinetic parameters and subsequent acute rejection in renal transplant recipients.

  1988cites this paper
• Serum cyclosporine kinetic profile. Failure to correlate with nephrotoxicity or rejection episodes following sequential immunotherapy for renal transplantation.

  1988cites this paper